Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Equity Ratio (2010 - 2026)

Harvard Bioscience (HBIO) reported Equity Ratio of 0.13 for Q1 2026, down 30.66% year-over-year from 0.19 in Q1 2025, and down 24.85% on a QoQ basis from 0.17 in Q4 2025.

Harvard Bioscience (HBIO) has 17 years of Equity Ratio data on file, last reported at 0.13 in Q1 2026.

  • Quarterly Equity Ratio fell 30.66% year-over-year to 0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.13 (down 30.66% YoY) and the FY2025 annual result came in at 0.17, down 65.71% from the prior year.
  • Equity Ratio slipped to 0.13 in Q1 2026 per HBIO's latest filing, from 0.17 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.53 in Q4 2023 and bottomed at 0.13 in Q1 2026.
  • The 5-year median for Equity Ratio is 0.5 (2024), against an average of 0.41.
  • The widest annual swing landed in 2023, when Equity Ratio increased 8.58%; it then sank 65.71% in 2025.
  • Tracing HBIO's Equity Ratio over 5 years: stood at 0.5 in 2022, then gained by 7.07% to 0.53 in 2023, then declined by 5.98% to 0.5 in 2024, then slumped by 65.71% to 0.17 in 2025, then declined by 24.85% to 0.13 in 2026.
  • Per Business Quant, the three latest HBIO Equity Ratio figures stand at 0.13 (Q1 2026), 0.17 (Q4 2025), and 0.18 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.88
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.47
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.73
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.35
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.67
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.66
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.30
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.52
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn 0.13

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.13
Dec 31, 2025 0.17
Sep 30, 2025 0.18
Jun 30, 2025 0.20
Mar 31, 2025 0.19
Dec 31, 2024 0.50
Sep 30, 2024 0.50
Jun 30, 2024 0.52
Mar 31, 2024 0.52
Dec 31, 2023 0.53
Sep 30, 2023 0.53
Jun 30, 2023 0.53
Mar 31, 2023 0.51
Dec 31, 2022 0.50
Sep 30, 2022 0.49
Jun 30, 2022 0.50
Mar 31, 2022 0.48
Dec 31, 2021 0.51
Sep 30, 2021 0.50
Jun 30, 2021 0.51
Mar 31, 2021 0.51
Dec 31, 2020 0.49
Sep 30, 2020 0.52
Jun 30, 2020 0.50
Mar 31, 2020 0.49
Dec 31, 2019 0.50
Sep 30, 2019 0.47
Jun 30, 2019 0.48
Mar 31, 2019 0.47
Dec 31, 2018 0.49
Sep 30, 2018 0.49
Jun 30, 2018 0.47
Mar 31, 2018 0.46
Dec 31, 2017 0.74
Sep 30, 2017 0.69
Jun 30, 2017 0.69
Mar 31, 2017 0.68
Dec 31, 2016 0.67
Sep 30, 2016 0.68
Jun 30, 2016 0.67
Mar 31, 2016 0.66
Dec 31, 2015 0.65
Sep 30, 2015 0.71
Jun 30, 2015 0.68
Mar 31, 2015 0.67
Dec 31, 2014 0.70
Sep 30, 2014 0.71
Jun 30, 2014 0.71
Mar 31, 2014 0.71
Dec 31, 2013 0.70
Sep 30, 2013 0.73
Jun 30, 2013 0.72
Mar 31, 2013 0.77
Dec 31, 2012 0.78
Sep 30, 2012 0.77
Jun 30, 2012 0.76
Mar 31, 2012 0.75
Dec 31, 2011 0.75
Sep 30, 2011 0.76
Jun 30, 2011 0.75
Dec 31, 2010 0.72